GSK
Stock Details
GSK is GSK plc's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 35.00$. Average daily volumn in 3 months 5.27M. Market cap 71.85B
Stock symbol : GSK. Exchange : NYSE. Currency : USD Lastest price : 35.10$. Total volume : 330.30k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
GSK plc (GSK)
Last Price
35.10$Change
-0.02Volume
330.30k
Previous Close | 35.12 |
Open | 35.56 |
Day Range | 35.10-35.42 |
Bid | 35.44 x 1.8k |
Ask | 35.46 x 1.1k |
Volume | 330.3k |
Average Volume | 5.27M |
Market Cap | 71.85B |
Beta | 0.29 |
52 Week Range | 28.47-46.97 |
Trailing P/E | 12.95 |
Foward P/E | 9.72 |
Dividend (Yield %) | 5.37% |
Ex-Dividend Date | 2022-11-17 |
Financial Details

Organization
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory... , HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Wave Life Sciences Ltd.; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Market Cap:
71.85BRevenue:
34.11BTotal Assets:
79.1BTotal Cash:
4.27B
News about "GSK plc"
GSK's Earnings Expected to Grow in 4Q Despite Sales Dip -- Earnings Preview
Source from : MarketWatch - 13 hours ago
GSK PLC is scheduled to report results for the fourth quarter on Feb 1. Here's what you need to know: SALES FORECAST: Sales at the British pharma major are expected to be 7.07 billion pounds ($8.73 ...See details»
How Do Things Look For GSK plc (NYSE: GSK) In The Short-Term?
Source from : stocksregister - 1 days ago
GSK plc (NYSE:GSK) price is hovering higher on Monday, January 30, jumping 0.25% above its previous close. A look at todayโs price movement shows that the recent level at last check reads $35.30, with ...See details»
BRIEF-Gsk PLC Reports 10.95% Passive Stake In Wave Life Sciences Ltd
Source from : Reuters - 1 days ago
GSK PLC REPORTS 10.95% PASSIVE STAKE IN WAVE LIFE SCIENCES LTD. AS OF JANUARY 23, 2023 - SEC FILING Further company coverage: ...See details»
GSK plc (GSK) and the Battle of Fundamentals vs. Technicals
Source from : newsheater - 6 month ago
GSK plc (NYSE:GSK) went down by -0.06% from its latest closing price compared to the recent 1-year high of $47.82. The companyโs stock price has collected -0.06% of loss in the last five trading ...See details»
Does GSK plc (NYSE: GSK) Still Need To Convince Analysts?
Source from : stocksregister - 6 days ago
GSK plc (NYSE:GSK) traded at $34.70 at close of the session on Tuesday, 01/24/23, made a downward move of -1.87% on its previous dayโs price. Looking at the stock we see that its previous close was ...See details»
GSK financials should look good but clinic is the focus
Source from : Proactiveinvestors - 4 days ago
GSK PLC (LSE:GSK, NYSE:GSK) has done well enough since the Haleon consumer products arm was spun out last year, though after a decent run-up to the end of 2022, shares have gone a bit flat since.See details»
GSK falls Tuesday, underperforms market
Source from : MarketWatch - 7 days ago
Shares of GSK PLC dropped 1.69% to ยฃ13.87 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 ...See details»
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Source from : Nasdaq - 28 days ago
The company changed its name to GSK plc from GlaxoSmithKline plc in mid-May 2022. In July 2022, GSK de-merged its Consumer Healthcare (CHC) segment into a standalone company. The independent ...See details»
GSK plc (GSK) Reveals an Earnings Mystery
Source from : newsheater - 6 month ago
GSK plc (NYSE:GSK) went down by -1.04% from its latest closing price compared to the recent 1-year high of $47.82. The companyโs stock price has collected 1.30% of gains in the last five trading ...See details»
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
Source from : Yahoo News - 1 month ago
GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a 'bidding war.' Luke ...See details»
GSK plc: Reaffirming BUY as company advances pipeline
Source from : Yahoo Finance - 22 days ago
GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical products. The company's leading products include ...See details»
GSK plc (GSK) Presents at 41st Annual JPMorgan Healthcare Conference (Transcript)
Source from : Seeking Alpha - 21 days ago
I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the GSK presentation. You're going to hear from GSK, CEO, Emma Walmsley, and we can ...See details»
GSK growing optimistic on HIV but long term challenges remain - analyst
Source from : Proactiveinvestors - 18 days ago
GSK shows increasing confidence in new HIV treatments but longer term challenges remain, according to Jefferies GSK PLC (LSE:GSK, NYSE:GSK) is growing at a "robust" rate and showing increasing ...See details»
GlaxoSmithKline plc
Source from : Fortune - 3 years ago
ยฉ 2022 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»